These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10335780)

  • 1. Prophylaxis against contrast-induced nephropathy.
    Oliveira DB
    Lancet; 1999 May; 353(9165):1638-9. PubMed ID: 10335780
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of contrast-induced nephropathy: an overview.
    Ellis JH; Cohan RH
    Radiol Clin North Am; 2009 Sep; 47(5):801-11, v. PubMed ID: 19744595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water for contrast-induced nephropathy? A thirst for knowledge.
    Pate GE; Webb JG
    J Invasive Cardiol; 2003 Dec; 15(12):703-5. PubMed ID: 14660822
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contrast-induced nephropathy].
    Westenfeld R; Rump LC
    Dtsch Med Wochenschr; 2013 Apr; 138(14):715-8. PubMed ID: 23533037
    [No Abstract]   [Full Text] [Related]  

  • 5. N-acetylcysteine and contrast-induced nephropathy.
    Aguiar-Souto P; Valero-González S; Domínguez JF
    N Engl J Med; 2006 Oct; 355(14):1497-8; author reply 1499-500. PubMed ID: 17021328
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing nephropathy induced by contrast medium.
    Hellman RN
    N Engl J Med; 2006 Apr; 354(17):1853-5; author reply 1853-5. PubMed ID: 16642595
    [No Abstract]   [Full Text] [Related]  

  • 7. N-acetylcysteine and contrast-induced nephropathy.
    Ritz E
    N Engl J Med; 2006 Oct; 355(14):1499; author reply 1499-500. PubMed ID: 17024738
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast-induced nephropathy: prevention and management of high-risk patients.
    Caixeta A; Nikolsky E; Mehran R
    Indian Heart J; 2008; 60(6):524-31. PubMed ID: 19276490
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
    Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
    Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.
    Marenzi G; Lauri G; Campodonico J; Marana I; Assanelli E; De Metrio M; Grazi M; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
    Am J Med; 2006 Feb; 119(2):155-62. PubMed ID: 16443418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice. Preventing nephropathy induced by contrast medium.
    Barrett BJ; Parfrey PS
    N Engl J Med; 2006 Jan; 354(4):379-86. PubMed ID: 16436769
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contrast substances-induced nephropathy].
    Mironova OIu
    Ter Arkh; 2013; 85(6):90-5. PubMed ID: 23875199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
    Huber W; Eckel F; Hennig M; Rosenbrock H; Wacker A; Saur D; Sennefelder A; Hennico R; Schenk C; Meining A; Schmelz R; Fritsch R; Weiss W; Hamar P; Heemann U; Schmid RM
    Radiology; 2006 Jun; 239(3):793-804. PubMed ID: 16714461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contrast medica nephropathy. Better understanding of risk markers and follow up needed].
    Sterner G; Hellström M; Lagerqvist B; Aspelin P; Nyman U
    Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1737-42. PubMed ID: 19731735
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast-induced nephropathy: contrast material not required?
    Baumgarten DA; Ellis JH
    AJR Am J Roentgenol; 2008 Aug; 191(2):383-6. PubMed ID: 18647906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure.
    Masuda M; Yamada T; Mine T; Morita T; Tamaki S; Tsukamoto Y; Okuda K; Iwasaki Y; Hori M; Fukunami M
    Am J Cardiol; 2007 Sep; 100(5):781-6. PubMed ID: 17719320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions.
    Iyisoy A; Celik T; Yuksel UC; Bugan B; Isik E
    Int J Cardiol; 2009 May; 134(3):431-3; author reply 434. PubMed ID: 18501445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations for prevention of contrast-media induced nepropathy].
    Arkouche W; Brillet G; Cao-Huu T; Issad B; Siohan P; Souid M; Stroumza P; Tollis F; Urena P; Pengloan J;
    Nephrologie; 2004; 25(4):149-50. PubMed ID: 15291145
    [No Abstract]   [Full Text] [Related]  

  • 19. Contrast-induced nephropathy.
    Baerlocher MO; Asch M; Myers A
    CMAJ; 2010 Sep; 182(13):1445. PubMed ID: 20547713
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing acute decrease in renal function induced by coronary angiography (PRECORD): a prospective randomized trial.
    Angoulvant D; Cucherat M; Rioufol G; Finet G; Beaune J; Revel D; Laville M; Ovize M; André-Fouët X
    Arch Cardiovasc Dis; 2009 Nov; 102(11):761-7. PubMed ID: 19944392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.